Literature DB >> 22753054

Genomic variation among contemporary Pseudomonas aeruginosa isolates from chronically infected cystic fibrosis patients.

Jade C S Chung1, Jennifer Becq, Louise Fraser, Ole Schulz-Trieglaff, Nicholas J Bond, Juliet Foweraker, Kenneth D Bruce, Geoffrey P Smith, Martin Welch.   

Abstract

The airways of individuals with cystic fibrosis (CF) often become chronically infected with unique strains of the opportunistic pathogen Pseudomonas aeruginosa. Several lines of evidence suggest that the infecting P. aeruginosa lineage diversifies in the CF lung niche, yet so far this contemporary diversity has not been investigated at a genomic level. In this work, we sequenced the genomes of pairs of randomly selected contemporary isolates sampled from the expectorated sputum of three chronically infected adult CF patients. Each patient was infected by a distinct strain of P. aeruginosa. Single nucleotide polymorphisms (SNPs) and insertions/deletions (indels) were identified in the DNA common to the paired isolates from different patients. The paired isolates from one patient differed due to just 1 SNP and 8 indels. The paired isolates from a second patient differed due to 54 SNPs and 38 indels. The pair of isolates from the third patient both contained a mutS mutation, which conferred a hypermutator phenotype; these isolates cumulatively differed due to 344 SNPs and 93 indels. In two of the pairs of isolates, a different accessory genome composition, specifically integrated prophage, was identified in one but not the other isolate of each pair. We conclude that contemporary isolates from a single sputum sample can differ at the SNP, indel, and accessory genome levels and that the cross-sectional genomic variation among coeval pairs of P. aeruginosa CF isolates can be comparable to the variation previously reported to differentiate between paired longitudinally sampled isolates.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22753054      PMCID: PMC3430303          DOI: 10.1128/JB.01050-12

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  46 in total

1.  Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients.

Authors:  Eric E Smith; Danielle G Buckley; Zaining Wu; Channakhone Saenphimmachak; Lucas R Hoffman; David A D'Argenio; Samuel I Miller; Bonnie W Ramsey; David P Speert; Samuel M Moskowitz; Jane L Burns; Rajinder Kaul; Maynard V Olson
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-10       Impact factor: 11.205

2.  Activation of the Pseudomonas aeruginosa AlgU regulon through mucA mutation inhibits cyclic AMP/Vfr signaling.

Authors:  Adriana K Jones; Nanette B Fulcher; Grant J Balzer; Mark L Urbanowski; Christopher L Pritchett; Michael J Schurr; Timothy L Yahr; Matthew C Wolfgang
Journal:  J Bacteriol       Date:  2010-09-03       Impact factor: 3.490

3.  A procaryotic regulatory factor with a histone H1-like carboxy-terminal domain: clonal variation of repeats within algP, a gene involved in regulation of mucoidy in Pseudomonas aeruginosa.

Authors:  V Deretic; W M Konyecsni
Journal:  J Bacteriol       Date:  1990-10       Impact factor: 3.490

4.  High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection.

Authors:  A Oliver; R Cantón; P Campo; F Baquero; J Blázquez
Journal:  Science       Date:  2000-05-19       Impact factor: 47.728

5.  Analysis of quorum sensing-deficient clinical isolates of Pseudomonas aeruginosa.

Authors:  J Andy Schaber; Nancy L Carty; Naomi A McDonald; Eric D Graham; Rajkumar Cheluvappa; John A Griswold; Abdul N Hamood
Journal:  J Med Microbiol       Date:  2004-09       Impact factor: 2.472

6.  The Pseudomonas aeruginosa quinolone signal molecule overcomes the cell density-dependency of the quorum sensing hierarchy, regulates rhl-dependent genes at the onset of stationary phase and can be produced in the absence of LasR.

Authors:  Stephen P Diggle; Klaus Winzer; Siri Ram Chhabra; Kathryn E Worrall; Miguel Cámara; Paul Williams
Journal:  Mol Microbiol       Date:  2003-10       Impact factor: 3.501

7.  DNA gyrase gyrA mutations in quinolone-resistant clinical isolates of Pseudomonas aeruginosa.

Authors:  M Yonezawa; M Takahata; N Matsubara; Y Watanabe; H Narita
Journal:  Antimicrob Agents Chemother       Date:  1995-09       Impact factor: 5.191

Review 8.  The role of quorum sensing in chronic cystic fibrosis Pseudomonas aeruginosa infections.

Authors:  Craig Winstanley; Joanne L Fothergill
Journal:  FEMS Microbiol Lett       Date:  2008-10-29       Impact factor: 2.742

9.  The flagellum of Pseudomonas aeruginosa is required for resistance to clearance by surfactant protein A.

Authors:  Shiping Zhang; Francis X McCormack; Roger C Levesque; George A O'Toole; Gee W Lau
Journal:  PLoS One       Date:  2007-06-27       Impact factor: 3.240

Review 10.  Recent advances in the microbiology of respiratory tract infection in cystic fibrosis.

Authors:  Juliet Foweraker
Journal:  Br Med Bull       Date:  2009-01-20       Impact factor: 4.291

View more
  48 in total

Review 1.  Pseudomonas aeruginosa AmpR: an acute-chronic switch regulator.

Authors:  Deepak Balasubramanian; Hansi Kumari; Kalai Mathee
Journal:  Pathog Dis       Date:  2015-02-26       Impact factor: 3.166

2.  Hypermutator Pseudomonas aeruginosa Exploits Multiple Genetic Pathways To Develop Multidrug Resistance during Long-Term Infections in the Airways of Cystic Fibrosis Patients.

Authors:  C A Colque; A G Albarracín Orio; S Feliziani; R L Marvig; A R Tobares; H K Johansen; S Molin; A M Smania
Journal:  Antimicrob Agents Chemother       Date:  2020-04-21       Impact factor: 5.191

3.  Mutations in Gene fusA1 as a Novel Mechanism of Aminoglycoside Resistance in Clinical Strains of Pseudomonas aeruginosa.

Authors:  Arnaud Bolard; Patrick Plésiat; Katy Jeannot
Journal:  Antimicrob Agents Chemother       Date:  2018-01-25       Impact factor: 5.191

4.  Use of a Multiplex Transcript Method for Analysis of Pseudomonas aeruginosa Gene Expression Profiles in the Cystic Fibrosis Lung.

Authors:  Alex H Gifford; Sven D Willger; Emily L Dolben; Lisa A Moulton; Dana B Dorman; Heather Bean; Jane E Hill; Thomas H Hampton; Alix Ashare; Deborah A Hogan
Journal:  Infect Immun       Date:  2016-09-19       Impact factor: 3.441

5.  Social cheating in a Pseudomonas aeruginosa quorum-sensing variant.

Authors:  Ruiyi Chen; Eric Déziel; Marie-Christine Groleau; Amy L Schaefer; E Peter Greenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2019-03-07       Impact factor: 11.205

6.  Evolution of the Pseudomonas aeruginosa Aminoglycoside Mutational Resistome In Vitro and in the Cystic Fibrosis Setting.

Authors:  Carla López-Causapé; Rosa Rubio; Gabriel Cabot; Antonio Oliver
Journal:  Antimicrob Agents Chemother       Date:  2018-03-27       Impact factor: 5.191

7.  Divergent, coexisting Pseudomonas aeruginosa lineages in chronic cystic fibrosis lung infections.

Authors:  David Williams; Benjamin Evans; Sam Haldenby; Martin J Walshaw; Michael A Brockhurst; Craig Winstanley; Steve Paterson
Journal:  Am J Respir Crit Care Med       Date:  2015-04-01       Impact factor: 21.405

8.  A Winogradsky-based culture system shows an association between microbial fermentation and cystic fibrosis exacerbation.

Authors:  Robert A Quinn; Katrine Whiteson; Yan-Wei Lim; Peter Salamon; Barbara Bailey; Simone Mienardi; Savannah E Sanchez; Don Blake; Doug Conrad; Forest Rohwer
Journal:  ISME J       Date:  2015-03-17       Impact factor: 10.302

Review 9.  Pseudomonas aeruginosa adaptation and evolution in patients with cystic fibrosis.

Authors:  Elio Rossi; Ruggero La Rosa; Jennifer A Bartell; Rasmus L Marvig; Janus A J Haagensen; Lea M Sommer; Søren Molin; Helle Krogh Johansen
Journal:  Nat Rev Microbiol       Date:  2020-11-19       Impact factor: 60.633

10.  Intraclonal genome diversity of Pseudomonas aeruginosa clones CHA and TB.

Authors:  Oliver Ki Bezuidt; Jens Klockgether; Sylvie Elsen; Ina Attree; Colin F Davenport; Burkhard Tümmler
Journal:  BMC Genomics       Date:  2013-06-22       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.